Novartis Pharma B.V.
Location
Noord-Holland
Founded
1948-02-10
Website
Risk Signals
21154 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Drugs, Drug Proprietaries, and Druggists' Sundries), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Novartis Pharma B.V.
Live alerts from global media, monitored by Business Radar
2025-04-14 (investors.com)
Novartis ADR Scores Relative Strength Rating Upgrade; Hits Key Benchmark | Investor's Business Daily
A Relative Strength Rating upgrade for Novartis ADR shows improving technical performance.
Read more2024-11-01 (pagenews.gr)
The process for the Novartis trial is at a turning point
News - The concern of the politicians involved is widespread. for pulling the "hood" from protected witnesses
Read more
2024-11-01 (benzinga.com)
Positive Outlook For Novartis As Company Capitalizes On Growing Treatment Opportunities, Analyst Highlights - Novartis (NYSE:NVS)
Novartis aims to enhance Pluvicto's market presence while exploring growth in multiple sclerosis and expanding its radioligand therapy portfolio.
Read more
2024-10-31 (moomoo.com)
Positive Outlook For Novartis As Company Capitalizes On Growing Treatment Opportunities, Analyst Highlights
OnTuesday, Novartis AG (NYSE:NVS) reported third-quarter sales of $12.823 billion, up 9% (+10% on constant currency), beating the consensus of $12.76 billion.Guidance: Novartis also raised its 2024
Read more
2024-10-31 (crisismonitor.gr)
A quasi-judicial coup at Novartis
The decision of the Greek Court of Justice to summon previously protected witnesses as suspects in the Novartis scandal is causing concern in Europe, as it undermines the guarantees of protection for Public Interest witnesses and sends a message of revenge with judicial backs.
Read more
2024-10-31 (crisismonitor.gr)
A quasi-judicial coup at Novartis
The decision of the Greek Court of Justice to summon previously protected witnesses as suspects in the Novartis scandal is causing concern in Europe, as it undermines the guarantees of protection for Public Interest witnesses and sends a message of revenge with judicial backs.
Read more2024-10-28 (healthtalk.no)
The industry reacts to errors in tenders: - Surprising and worrying
Several pharmaceutical companies participating in the ongoing TNF-BIO tender express strong concerns about an error that was made in the tender ranking. Several react particularly to the lack of communication from Hospital Purchasing.
Read more
2024-10-26 (parapolitika.gr)
Novartis scandal: Concern in SYRIZA for new revelations, when the protected witnesses open their mouths
The rapid developments of the last 24 hours regarding the entire history of Novartis seem to be causing strong seismic vibrations in the political arena, especially in the SYRIZA of the Tsipras administration.
Read more
2024-10-26 (parapolitika.gr)
Novartis scandal: Concern in SYRIZA for new revelations, when the protected witnesses open their mouths
The rapid developments of the last 24 hours regarding the entire history of Novartis seem to be causing strong seismic vibrations in the political arena, especially in the SYRIZA of the Tsipras administration.
Read more2024-09-14 (secoloditalia.it)
Southern Italy, new investments underway with the Zes. Meloni: “Competitiveness and work, the south starts from here”
New investments for the South thanks to the opportunities of the Zes: the satisfaction of Giorgia Meloni and Minister Fitto
Read more2024-09-14 (telemia.it)
Zes Unica, new industrial authorizations including Fontenoce in Calabria. But important critical issues remain for small businesses.
Today, the Government Mission Structure gave the green light to a series of significant projects that concern various Italian regions
Read more2024-09-14 (la-notizia.net)
Unique SEZ in the South, the government's actions
Single SEZ of the South, the government's actions - The Government's action continues aimed at allowing, with simplified procedures
Read more